CLYBL and neuroblastoma: ALK is a known oncogenic driver for ALK-driven NB cell lines including CLB-BAR, CLB-GAR, CLB-GE, and NB1, and inhibition of ALK activity with ALK inhibitors has been shown to block their proliferation [26,27,28,34].